According to the latest National Alliance of Healthcare Purchaser Coalitions survey, 31% of U.S. employers have chosen a transparent pharmacy benefit manager (PBM) – that's up from 12% in 2024. This increase reflects a major industry shift. In just one year, employer contracts with the “Big Three” PBMs – CVS Caremark, Express Scripts, and OptumRx – dropped from 72% to 61%, while transparent PBM partnerships jumped from 12% to 31%. Survey results show that employers are feeling heightened pressure from rising healthcare costs – 53% strongly agreed it affects their ability to compete, compared to 35% in 2022. As regulatory pressure and demand for transparency surges, more employers are seeking out mid-market PBMs that offer innovative approaches to managing drug spend.
Contact a dedicated ProAct Sales Director to learn how we can support the needs of employer groups looking for greater transparency, more control, and flexibility in coverage options. Email us today: ProActSalesTeam@proactrx.com
